- Home
- AARD vs ZVIA Comparison
AARD vs ZVIA Comparison
Compare AARD & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AARD | ZVIA |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.7M | 126.3M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AARD | ZVIA |
|---|---|---|
| Price | $4.46 | $1.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $11.11 | $3.96 |
| AVG Volume (30 Days) | 109.7K | ★ 364.2K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.11 | ★ 55.88 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.02 |
| Revenue Next Year | N/A | $6.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.01 |
| 52 Week Low | $3.35 | $1.11 |
| 52 Week High | $16.60 | $2.78 |
Technical Indicators
Market Signals| Indicator | AARD | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 35.55 |
| Support Level | $3.38 | $1.13 |
| Resistance Level | $5.88 | $1.50 |
| Average True Range (ATR) | 0.45 | 0.06 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 0.00 | 5.08 |
Price Performance
Historical ComparisonAbout AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.